Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -10,073 | -11,255 | N/A |
| Depreciation Amortization | 113 | 119 | N/A |
| Accounts receivable | -2 | 16 | N/A |
| Accounts payable and accrued liabilities | 40 | -951 | N/A |
| Other Working Capital | 701 | -298 | N/A |
| Other Operating Activity | 763 | 1,076 | 0 |
| Operating Cash Flow | $-8,458 | $-11,293 | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -6,889 | 11,010 | N/A |
| PPE Investments | 658 | N/A | N/A |
| Investing Cash Flow | $-6,231 | $11,010 | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 4,853 | N/A | N/A |
| Debt Repayment | N/A | -12 | N/A |
| Common Stock Issued | 26,514 | N/A | N/A |
| Other Financing Activity | -3 | 0 | 0 |
| Financing Cash Flow | $31,364 | $-12 | $N/A |
| Beginning Cash Position | 7,726 | 8,021 | N/A |
| End Cash Position | 24,401 | 7,726 | N/A |
| Net Cash Flow | $16,675 | $-295 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -8,458 | -11,293 | N/A |
| Free Cash Flow | -8,458 | -11,293 | 0 |